NCT00322205View on ClinicalTrials.gov

Bio-behavioral Lung Cancer Prevention Program

PHASE4CompletedINTERVENTIONAL

Enrollment

555

Participants

Timeline

Start Date

June 30, 1999

Study Completion Date

March 31, 2002

Conditions

Smoking Cessation

Interventions

DRUG

zyban

Trial Locations (1)

Unknown

State University of New York, Buffalo

All Listed Sponsors

lead

National Institutes of Health (NIH)

NIH

NCT00322205 - Bio-behavioral Lung Cancer Prevention Program | Biotech Hunter | Biotech Hunter